FDA approves first rapid-acting insulin biosimilar for patients with diabetes
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
Ever-Growing USA on MSN1d
Retratutide: A New Dawn in the Treatment of Obesity and Type 2 Diabetes
In the ever-evolving landscape of healthcare, groundbreaking innovations are not merely celebrated for their scientific ...
Nature3mon
Getting biological about the genetics of diabetes
The first round of genome-wide association studies has not accounted for common human diseases to the extent ... or overweight has doubled in that time frame, owing to changes in diet and other ...
News Medical on MSN13d
Comprehensive atlas of endothelial cells advances diabetes research
The distinct population of endothelial cells that line blood vessels in the insulin-producing "islets" of the human pancreas have been notoriously difficult to study, but Weill Cornell Medicine ...
Wegovy and Ozempic top list of 15 drugs up for next price negotiations
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of federal price negotiations, which are scheduled to begin this year, with ...
Interesting Engineering on MSN2d
FDA approves first-ever rapid-acting insulin biosimilar for diabetes treatment
The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...